FTY720 Modulating Microglia-Mediated Cholesterol Recycling via TREM2 Promotes Remyelination Following Ischemic Damage

Jian-Bing Yu1, Chen Hong1, Xue-Wei Ren1

  • 1Department of Pharmacology, Neuroprotective Drug Discovery Key Laboratory, Jiangsu Key Laboratory of Neurodegeneration, Nanjing Medical University, Jiangsu, China (J.-B.Y., C.H., X.-W.R., W.G., Y.-F.C., J.J., X.-Y.Z., X.-L.S.).

Stroke
|April 22, 2025
PubMed
Abstract

Insights

FTY720 treatment promotes remyelination after ischemic white matter damage by enhancing microglial cholesterol processing via TREM2, improving cognitive function and white matter integrity.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia clear cholesterol-rich myelin debris after ischemic white matter damage, forming lipid droplets.
  • The processing of engulfed myelin by microglia remains poorly understood.
  • FTY720 is identified as a high-affinity ligand for microglial TREM2 (triggering receptor expressed on myeloid cells 2).

Purpose of the Study:

  • To investigate the role of FTY720 targeting TREM2 in regulating microglial cholesterol metabolism during remyelination.
  • To assess FTY720's therapeutic potential in ischemic white matter damage.

Main Methods:

  • Induction of chronic ischemic white matter damage in mice via bilateral carotid artery stenosis.
  • Administration of FTY720 and evaluation of cognitive function, white matter integrity, and microglial lipid accumulation.
  • In vitro coculture systems to assess cholesterol transfer and remyelination efficacy.

Main Results:

  • FTY720 alleviated cognitive deficits and promoted remyelination in mice with ischemic white matter damage.
  • The therapeutic effects of FTY720 were dependent on TREM2 expression.
  • FTY720 facilitated microglial cholesterol efflux via TREM2-mediated ABCA1 redistribution and enhanced oligodendrocyte myelination.

Conclusions:

  • FTY720 regulates myelin-derived cholesterol recycling in microglia through TREM2.
  • This process supplies cholesterol to oligodendrocytes, supporting remyelination.
  • FTY720 represents a novel therapeutic target for ischemic white matter damage.

Related Concept Videos